A group of North Carolina health and science leaders is calling on the Environmental Protection Agency to release a long-awaited toxicity report on PFNA, a “forever chemical” found in drinking water ...

In the grainy, nostalgia-laden opening sequence of Fazil Razak’s sophomore film Moham (Desire), a young girl looks longingly at a motorcycle. Minutes later, when the scene cuts to a present day image ...

Federal judge blocks Whitmer from shutting down submerged Great Lakes pipeline Steven Spielberg’s "Disclosure Day" drop has everyone saying the same thing Archaeologists thought they found wires ...

Biden's own advisers warned his border policies could create 'chaos': report Another state suffers blow over truck driver licenses Hitmen ambush and kill journalist who covered corruption Texans vs.

That's why when I recently asked the BuzzFeed Community to share the job interview "red flags" that sent them running for the hills, I received dozens of responses, and I have no words. From asking ...

Republican Rep. Marjorie Taylor Greene said Sunday she will stop using “toxic” rhetoric, marking what would be a dramatic shift in a political brand hallmarked by derogatory comments. The commitment ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in mice to a hundred times its stand-alone effectiveness, thus offering ...

The next time you encounter an unusually polite reply on social media, you might want to check twice. It could be an AI model trying (and failing) to blend in with the crowd. On Wednesday, researchers ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans, leading to multiple organ failure. Another example, ...

It’s widely known that social media can quickly turn into a toxic cesspool of hate speech and ragebait, particularly during times of political turmoil. Across social media platforms, amplified by the ...

Eli Lilly has halted development of a phase 2 P2X7 inhibitor for pain, the company confirmed to Fierce Biotech, in the latest shakeup to a pipeline that has already seen significant pivots this year.